Patent Loophole Brings Life-Saving Cystic Fibrosis Drug to Patients Who Can’t Afford It A powerful story about how a patent law loophole in Bangladesh gave cystic fibrosis patients access to a life-saving drug that costs $346,000 a year in the United States, raising important questions about innovation, patents, and healthcare access.
Read more